We are live on ! Find out more
OSIR

Osiris Therapeutics, Inc. Common Stock
OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

68 hedge funds and large institutions have $36.2M invested in Osiris Therapeutics, Inc. Common Stock in 2016 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 22 increasing their positions, 17 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

29% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 17

23% more call options, than puts

Call options by funds: $311K | Put options by funds: $253K

11% less capital invested

Capital invested by funds: $41M → $36.2M (-$4.7M)

15% less funds holding

Funds holding: 8068 (-12)

56% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 18

Holders
68
Holders Change
-12
Holders Change %
-15%
% of All Funds
1.81%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
8
Increased
22
Reduced
17
Closed
18
Calls
$311K
Puts
$253K
Net Calls
+$58K
Net Calls Change
+$1M
Name Holding Trade Value Shares
Change
Change in
Stake
ProShare Advisors
26
ProShare Advisors
Maryland
$143K +$2.34K +434 +2%
TA
27
Teachers Advisors
New York
$141K
Federated Hermes
28
Federated Hermes
Pennsylvania
$131K +$41.2K +7,652 +42%
State Board of Administration of Florida Retirement System
29
State Board of Administration of Florida Retirement System
Florida
$120K
Jacobs Levy Equity Management
30
Jacobs Levy Equity Management
New Jersey
$117K -$188K -34,868 -60%
ARTA
31
A.R.T. Advisors
New York
$117K +$124K +23,049 New
HK
32
Horizon Kinetics
New York
$107K
Bank of Montreal
33
Bank of Montreal
Ontario, Canada
$101K
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$100K +$512 +95 +0.5%
PP
35
PDT Partners
New York
$99K +$105K +19,500 New
California Public Employees Retirement System
36
California Public Employees Retirement System
California
$98K -$3.77K -700 -4%
Two Sigma Advisers
37
Two Sigma Advisers
New York
$96K -$1.08K -200 -1%
New York State Common Retirement Fund
38
New York State Common Retirement Fund
New York
$96K
CLOS
39
Compagnie Lombard Odier SCmA
Switzerland
$92K
Wells Fargo
40
Wells Fargo
California
$82K -$6.92K -1,285 -7%
Bank of America
41
Bank of America
North Carolina
$79K +$18.9K +3,519 +29%
Group One Trading
42
Group One Trading
Illinois
$78K -$252K -46,805 -75%
CS
43
Credit Suisse
Switzerland
$76K -$45.2K -8,398 -36%
AIM
44
Acrospire Investment Management
Illinois
$69K +$11.9K +2,218 +20%
HCM
45
Highbridge Capital Management
New York
$69K +$73.3K +13,610 New
KBC Group
46
KBC Group
Belgium
$65K +$68.4K +12,694 New
NFA
47
Nationwide Fund Advisors
Ohio
$63K
PPA
48
Parametric Portfolio Associates
Washington
$62K +$65.7K +12,201 New
Public Employees Retirement Association of Colorado
49
Public Employees Retirement Association of Colorado
Colorado
$61K
Citigroup
50
Citigroup
New York
$59K -$45.2K -8,399 -42%

OSIR Hedge Fund Activity: Q2 2016 in Review

68 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q2 2016, worth a combined $36.2M — down 11% from $41M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of OSIR and 8 opened new positions — a net loss of 10 holders — while 17 trimmed existing stakes and 22 added.

The largest buyer was Deutsche Bank, adding an estimated $666K. The largest seller was Two Sigma Investments, exiting entirely with an estimated $446K sold.

  • 68 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q2 2016, down from 80 in Q1 2016.
  • Funds reported $36.2M of Osiris Therapeutics, Inc. Common Stock stock for Q2 2016, down 11% quarter-over-quarter.
  • 8 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q2 2016 and 18 closed out, a net change of -10 holders.
  • The largest Osiris Therapeutics, Inc. Common Stock buyer in Q2 2016 was Deutsche Bank, an estimated $666K added.
  • The largest Osiris Therapeutics, Inc. Common Stock seller in Q2 2016 was Two Sigma Investments, an estimated $446K sold.

Based on aggregated 13F filings for Q2 2016.